EK108EGA

EasyGo!™ Human IL-8 One-Step ELISA Kit 检测试剂盒(酶联免疫吸附法)

X

¥2,190.00¥3,650.00

  • 分子靶点:CXCL8, IL-8, GCP1, NAP1
  • 种属:人 (Human)
  • 样本类型:血清,血浆
  • 检测样本体积:10 μL
  • 灵敏度:3.85 pg/mL
  • 检测范围:15.625 pg/mL - 1000 pg/mL
  • 回收率:85% - 122%

在售SKU:70-EK108EGA-48, 70-EK108EGA-96, EK108EGA, 人白细胞介素8, 白细胞介素8, 白细胞介素, 人, 白介素, 8, 一步法, 一步法ELISA, 一步法试剂盒, 一步法ELISA试剂盒


描述

商品名

EasyGo!™ Human IL-8 One-Step ELISA Kit 检测试剂盒(酶联免疫吸附法)

检测方法

双抗夹心法

精密度

板内变异系数:6.1% - 9.5%;板间变异系数:8.9% - 9.8%

样本类型

血清,血浆

检测样本体积

10 μL

灵敏度

3.85 pg/mL

检测范围

15.625 pg/mL - 1000 pg/mL

回收率

85% - 122%

平均回收率

1.02

板式

96孔板,可拆

保存

试剂盒未拆开,2 - 8℃保存。已拆开,标准品-20℃保存,其它2 - 8℃保存。

运输条件

4℃蓝冰运输

组分
  • 酶标板
  • 标准品
  • 标准品稀释液
  • 显色底物
  • 终止液
  • 20×洗液

检测原理:本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性捕获抗体预包被在高亲和力的酶标板上,酶标板孔中预先加入生物素标记的微球和辣根过氧化物酶微球。酶标板孔中加入标准品和待测样本,经过孵育,样本中存在的待测物质与捕获抗体和检测抗体结合。洗涤去除未结合的物质后,加入显色底物(TMB),避光显色。颜色反应的深浅与样本中待测物质的浓度成正比。加入终止液终止反应,在 450 nm 波长 (参考波长 5630 nm) 测定吸光度值。

EasyGo!™ Human IL-8 One-Step ELISA Kit EasyGo!™ 人白细胞介素8 (IL-8) 一步法酶联免疫吸附测定试剂盒 - 标准曲线
标准曲线

分子信息

概述人 CXCL8, IL-8, GCP1, NAP1 靶点信息

CXCL8 分子靶点信息概述

  • 分子名:CXCL8, C-X-C motif chemokine ligand 8
  • 基因家族:Chemokine ligands; Interleukins
  • 别名:SCYB8; LUCT; LECT; MDNCF; TSG-1; IL-8; NAP-1; 3-10C; MONAP; AMCF-I; LYNAP; NAF; b-ENAP; GCP-1; K60; GCP1; NAP1
  • 曾用名:IL8
  • 全称:neutrophil-activating peptide 1; granulocyte chemotactic protein 1; monocyte-derived neutrophil chemotactic factor; lung giant cell carcinoma-derived chemotactic protein; tumor necrosis factor-induced gene 1; monocyte-derived neutrophil-activating peptide; lymphocyte derived neutrophil activating peptide; beta endothelial cell-derived neutrophil activating peptide; alveolar macrophage chemotactic factor I; interleukin 8; chemokine (C-X-C motif) ligand 8

CXCL8 分子靶点综述

白细胞介素8(IL-8)是由巨噬细胞和其它类型细胞如上皮细胞、气道平滑肌细胞和内皮细胞产生的趋化因子,在人类中,由IL8基因编码。IL-8可有效促进血管生成,在细支气管炎的发病机制中起重要作用。IL-8可通过对中性粒细胞的召集和脱颗粒来实现对炎症反应的调节,可作为结肠癌细胞株的自分泌生长因子来作用于结肠直肠癌。高水平的IL-8可减少精神分裂症患者抗精神病药的阳性反应。另外,IL-8与肥胖和囊性纤维化的发病机制也相关。

人 Human CXCL8 分子靶点信息

  • 分子名:CXCL8, C-X-C motif chemokine ligand 8
  • 别称:
    • alveolar macrophage chemotactic factor I
    • beta endothelial cell-derived neutrophil activating peptide
    • beta-thromboglobulin-like protein
    • C-X-C motif chemokine 8
    • chemokine (C-X-C motif) ligand 8
    • emoctakin
    • GCP-1
    • GCP1
    • granulocyte chemotactic protein 1
    • IL8
    • interleukin 8
    • interleukin-8
    • LECT
    • LUCT
    • lung giant cell carcinoma-derived chemotactic protein
    • lymphocyte derived neutrophil activating peptide
    • lymphocyte-derived neutrophil-activating factor
    • LYNAP
    • MDNCF
    • MONAP
    • monocyte-derived neutrophil chemotactic factor
    • monocyte-derived neutrophil-activating peptide
    • NAF
    • NAP-1
    • NAP1
    • neutrophil-activating peptide 1
    • SCYB8
    • small inducible cytokine subfamily B, member 8
    • T cell chemotactic factor
    • T-cell chemotactic factor
    • tumor necrosis factor-induced gene 1
  • 基因序列:NCBI_Gene: 3576
  • 蛋白序列:UniProtKB: P10145

人 Human CXCL8靶点分子功能(预测)

Enables chemokine activity and interleukin-8 receptor binding activity. Involved in several processes, including cellular response to cytokine stimulus; induction of positive chemotaxis; and neutrophil chemotaxis. Acts upstream of or within negative regulation of cell adhesion molecule production; positive regulation of cellular biosynthetic process; and regulation of gene expression. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Implicated in several diseases, including autoimmune uveitis; bacterial gastritis; gastrointestinal system cancer (multiple); trachoma; and urinary tract infection. Biomarker of several diseases, including chikungunya; cholestasis (multiple); cystic fibrosis; liver disease (multiple); and tuberculosis (multiple).

操作步骤


下载本产品说明书

ELISA操作常见问题

查看更多ELISA操作相关问题

引用文献